Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging
The study conducted by Loma Linda University aims to establish normative values for cerebral blood flow (CBF) across various brain regions using a novel MRI technique. This non-invasive method has potential applications in diagnosing and managing brain disorders such as traumatic brain injury, multiple sclerosis, and Alzheimer's disease. The successful establishment of normative CBF values could enhance the reliability of pCASL MRI in clinical settings, positioning it as a competitive alternative to existing imaging modalities. The market for advanced neuroimaging techniques is growing, driven by increasing incidences of neurological disorders and the demand for non-invasive diagnostic tools. Companies developing or utilizing similar imaging technologies may face competitive pressures, and the findings from this study could influence their product development strategies.
Indication: Traumatic Brain Injury
Modality: medical device
Target: Cerebral Blood Flow (CBF) measurement using pseudo-continuous arterial spin labeling (pCASL) MRI technique.
Sponsor: Loma Linda University
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 07, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Cerebral Blood Flow (CBF) measurement using pseudo-continuous arterial spin labeling (pCASL) MRI technique.
View original source fields
Condition raw: Traumatic Brain Injury, Multiple Sclerosis, Alzheimer's Disease, Tumor
Condition normalized: Traumatic Brain Injury, Multiple Sclerosis, Alzheimer's Disease, Tumor
Modality raw: medical device
Modality normalized: medical device
Target raw: Cerebral Blood Flow (CBF) measurement using pseudo-continuous arterial spin labeling (pCASL) MRI technique.
Target normalized: Cerebral Blood Flow (CBF) measurement using pseudo-continuous arterial spin labeling (pCASL) MRI technique.